No abstract available
Publication types
-
Consensus Development Conference
-
Practice Guideline
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Blood Glucose / drug effects
-
Blood Glucose / physiology
-
Diazoxide / therapeutic use
-
Everolimus
-
Humans
-
Hypoglycemia / etiology
-
Hypoglycemia / therapy*
-
Insulinoma / complications
-
Insulinoma / drug therapy
-
Octreotide / therapeutic use
-
Pancreatic Neoplasms / complications
-
Pancreatic Neoplasms / drug therapy
-
Protein Kinase Inhibitors / therapeutic use
-
Signal Transduction / physiology
-
Sirolimus / analogs & derivatives
-
Sirolimus / therapeutic use
-
Somatostatin / analogs & derivatives
-
Somatostatin / therapeutic use
-
TOR Serine-Threonine Kinases / antagonists & inhibitors
-
TOR Serine-Threonine Kinases / physiology
Substances
-
Antineoplastic Agents
-
Blood Glucose
-
Protein Kinase Inhibitors
-
Somatostatin
-
Everolimus
-
MTOR protein, human
-
TOR Serine-Threonine Kinases
-
Diazoxide
-
Octreotide
-
Sirolimus